ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,048.42
-0.46%
US Tech 100
17,202.80
0.83%
Dow Jones
38,085.80
-0.98%
Brent Oil
88.115
1.03%
Bitcoin
64,805.34
0.82%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Avenue Therapeutics Inc (ATXI) Quote

Avenue Therapeutics Inc

Avenue Therapeutics Inc (ATXI)

NASDAQ
0.117
0.0227
(24.07%)
At close: April 25 4:00PM
Delayed by 15 minutes
0.1001
0.0058
( 6.15% )
After Hours: 4:42PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.1001
Bid
0.10
Ask
0.1001
Volume
9,267,526
0.0865 Day's Range 0.12
0.0852 52 Week Range 1.25
Market Cap
1.59M
Previous Close
0.0943
Open
0.09
Last Trade
1
@
0.1001
Last Trade Time
16:44:34
Financial Volume
$ 925,817
VWAP
0.099899
Average Volume (3m)
1,681,088
Shares Outstanding
13,247,622
Dividend Yield
-
PE Ratio
-0.15
Earnings Per Share (EPS)
-0.78
Revenue
-
Net Profit
-10.38M

About Avenue Therapeutics Inc

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.avenuetx.com
Headquarters
Dover, Delaware, USA
Founded
1970
Avenue Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATXI. The last closing price for Avenue Therapeutics was $0.09. Over the last year, Avenue Therapeutics shares have traded in a share price range of $ 0.0852 to $ 1.25.

Avenue Therapeutics currently has 13,247,622 shares outstanding. The market capitalization of Avenue Therapeutics is $1.59 million. Avenue Therapeutics has a price to earnings ratio (PE ratio) of -0.15.

ATXI Latest News

More News

Avenue Therapeutics Announces Reverse Stock Split

MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and...

April 24 2024
GlobeNewswire Inc.

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and...

March 25 2024
GlobeNewswire Inc.

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

- Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in second quarter of 2024 - - Presented positive BAER-101 preclinical...

March 18 2024
GlobeNewswire Inc.

Avenue Therapeutics Receives Positive Listing Determination from Nasdaq

MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and...

March 15 2024
GlobeNewswire Inc.

Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

BAER-101 demonstrated full suppression of seizure activity in SynapCell's GAERS model of absence epilepsy, a proven indicator of efficacy in anti-seizure drug development with high predictability...

March 11 2024
GlobeNewswire Inc.

Form PRE 14C - Other preliminary information statements

March 08 2024
Edgar (US Regulatory)

Form 8-K - Current report

March 08 2024
Edgar (US Regulatory)

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

MIAMI, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

February 22 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

February 02 2024
Edgar (US Regulatory)

Form DEF 14C - Other definitive information statements

January 29 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.035-25.90673575130.13510.13770.085229917200.1004519CS
4-0.0494-33.04347826090.14950.15850.085213654210.1177421CS
12-0.0451-31.06060606060.14520.20.085216810880.14412206CS
26-0.4099-80.37254901960.510.510.085239064840.23375957CS
52-0.8601-89.57508852320.96021.250.085219771840.24808453CS
156-71.8999-99.86097222227283.550.085218055585.36426404CS
260-71.1499-99.859508771971.25188.40.085211371669.84482486CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TVGNTevogen Bio Holdings Inc
$ 1.25
(47.06%)
69.9k
GGLLDirexion Daily GOOGL Bull 2X ETF
$ 44.50
(23.54%)
99.79k
PEGYPineapple Energy Inc
$ 0.06
(15.61%)
19.17M
ELWSEarlyworks Co Ltd
$ 0.8297
(12.83%)
291.61k
GOOGLAlphabet Inc
$ 174.28
(11.72%)
5.85M
ACONAclarion Inc
$ 0.32
(-18.51%)
816.55k
VINCVincerx Inc
$ 0.7399
(-17.49%)
256.77k
ATXIAvenue Therapeutics Inc
$ 0.1006
(-14.02%)
230.86k
GGLSDirexion Daily GOOGL
$ 13.55
(-11.90%)
67.15k
BRFHBarfresh Food Group Inc
$ 1.63
(-10.44%)
275.86k
PEGYPineapple Energy Inc
$ 0.06
(15.61%)
19.17M
SQQQProShares UltraPro Short QQQ
$ 11.57
(-3.58%)
6.1M
GOOGLAlphabet Inc
$ 174.28
(11.72%)
5.85M
INTCIntel Corporation
$ 31.97
(-8.94%)
4.89M
ISUNiSun Inc
$ 0.1568
(-8.94%)
3.69M

ATXI Discussion

View Posts
jelaco jelaco 2 months ago
When is the Nas min compliance hearing.. anyone hear anything on that? Also, when's the r/s coming?
👍️0
Animas Animas 3 months ago
yea I flipped twice and loss twice.
👍️0
DeafTrader2 DeafTrader2 3 months ago
I flipped it . No longer holding this ticker .
👍️0
Animas Animas 3 months ago
Notice of Effectiveness: New Five Year Low .113
R/S Coming Soon, to Stay Alive.
👍️0
heyitsmeagain heyitsmeagain 3 months ago
Money
👍️0
81vette 81vette 3 months ago
Todays email to me from ATXI,approved increase of outstanding to 200m(from 75m) also warrants issued .30(also reduced previous to exercise at .30)reason was they only had 161k cash left(ran out of $) debt is now $191m
👍️0
glenn1919 glenn1919 3 months ago
ATXI..............................................https://stockcharts.com/h-sc/ui?s=ATXI&p=W&b=5&g=0&id=p86431144783
👍️0
DeafTrader2 DeafTrader2 3 months ago
Chart is improving ... Have bottomed out ..

YUUUPPPP
👍️0
DeafTrader2 DeafTrader2 3 months ago
Wow ! ... What Happened Back Then ? Curious
👍️0
DeafTrader2 DeafTrader2 3 months ago
IV Tramadol itself is a huge profit but are there other competitors that sell this drug ?
👍️0
DeafTrader2 DeafTrader2 3 months ago
Is this stock a good buy right now ? 200M o/s
👍️0
81vette 81vette 3 months ago
Filing states,approved raising o/s to 200M from 75M
👍️0
81vette 81vette 3 months ago
I lost on first try to play,waiting for a bullish sign to try again (maybe,lose more) volume fading out is bad also
👍️0
81vette 81vette 3 months ago
Buyout is best for shareholders short term with a big run and done
👍️ 1 💯 1 ☝️ 1
DeafTrader2 DeafTrader2 3 months ago
Is buy out a good thing for this ticker ?
👍️0
DeafTrader2 DeafTrader2 3 months ago
Bottomed Out ... Shoulda, coulda, woulda ..... ?
👍️0
RAlbert RAlbert 4 months ago
Why so? What am I missing here?
👍️0
DeafTrader2 DeafTrader2 4 months ago
Pendant northward ... sqeeze as FK
👍️0
DeafTrader2 DeafTrader2 4 months ago
I am pissed that I FLIPPED THIS Today .l.. STUPID
👍️0
81vette 81vette 4 months ago
Money raise warrants,ends tomorrow,ppl loading up,accumulation continues
🏁 1 👍️ 1 💯 1 ☝️ 1
DeafTrader2 DeafTrader2 4 months ago
this plane crashing back to this level ...
👍️0
TheFinalCD TheFinalCD 4 months ago
atxi .18's

get em while they're hot

LOL
👍️0
Sunset Kid Sunset Kid 4 months ago
Current O/S is 30M per dilution tracker. 90% were sold to investors in Nov and Jan. @ .30/share. Those transactions have provided $10M to the company for 2024 operating budget. https://dilutiontracker.com/app/search/ATXI
👍️0
Sunset Kid Sunset Kid 4 months ago
They sold 16.5 million shares (warrants) @ .30 for $5M. Funding for 2024 in place with less than 20M outstanding. This surge means something good is coming, imo. This is on everyones radar now. Let's squeeze the shorts to over a buck this week.
👍️0
Sunset Kid Sunset Kid 4 months ago
ATXI is #1 weekly and monthly gainer under a buck. Float has traded multipble times last week. Lets rock their world.
👍️0
glenn1919 glenn1919 4 months ago
ATXI...........................................https://stockcharts.com/h-sc/ui?s=ATXI&p=W&b=5&g=0&id=p86431144783
👍️0
Sauerkraut Sauerkraut 4 months ago
Yes. Worked out well. Now sell @.30 and stopp @.15.
Glty
👍️0
TheFinalCD TheFinalCD 4 months ago
correction .1981 avg

im tired

good weekend all
👍️0
TheFinalCD TheFinalCD 4 months ago
good call I had 20k bid @ .1625 it stops .1632 :/

MFalgoz

I bought 10k @ .2216 & 10K .175

holding 20k avg .2081

wonder if it tests .15 again?

may wait to see before I add more


38 to 18 what a shitshow
👍️0
RAlbert RAlbert 4 months ago
The warrants exercising at little over 30 cents is a good sign when compared with current share price. It is a steal to buy in at .185
👍️0
DeafTrader2 DeafTrader2 4 months ago
Will add position Monday and Tuesday
👍️0
81vette 81vette 4 months ago
Tripled my position with .185s,run started 17ish yesterday
👍️ 1 💯 1 ☝️ 1
DeafTrader2 DeafTrader2 4 months ago
Its a F.U. message from CEO ... !!!
👍️0
DeafTrader2 DeafTrader2 4 months ago
Avenue Therapeutics Shares Drop 42% After Warrants Exercised
👍️0
81vette 81vette 4 months ago
Ppl saying dilution,it’s warrants 20-50k orders,could run out (15m issued) before 9th (I wanted to say soon,but that’s just the greed/devil on my shoulder lol)
👍️0
81vette 81vette 4 months ago
Pr states “could be strategic partnership” bring on a big name pharma and that 1.55 will be pffft (could be why only raising 5m,make partner pay the 50m for study and phase 4-5 to market,or sell it for 300m,lots of speculation on many ppls minds,confidence to me would be insider’s buying,that might create big run up to the 1.55
👍️0
trendzone trendzone 4 months ago
Not in the stock price,but if someone keeps averaging down from much higher levels too many times,and the stock keeps tanking, they could find themselves in a situation of being down that much on the amount of money they originally invested.
👍️0
TheFinalCD TheFinalCD 4 months ago
at least we are doing better than IVP

what a falling knife that was
👍️0
81vette 81vette 4 months ago
$1.55 issued exercise,reduced price is .3006,closing on 9th
👍️0
TheFinalCD TheFinalCD 4 months ago
VWAP .2317


todays news didnt help https://www.globenewswire.com/news-release/2024/01/05/2804696/0/en/Avenue-Therapeutics-Enters-into-Warrant-Exercise-Transactions-for-5-0-Million-in-Proceeds.html
👍️0
Triple nickle Triple nickle 4 months ago
Yup in it avg’ing down thought it would go .18 but not happening
👍️0
Sauerkraut Sauerkraut 4 months ago
Bid @.17
👍️0
TheFinalCD TheFinalCD 4 months ago
how is anything down more than -100%

please tell us LL

Message in reply to:
If you were compared to a stock, you would be considered a toxic diluted OTC that's down over 300% from its highs.
👍️0
Sauerkraut Sauerkraut 4 months ago
Closing the Gap
👍️0
TheFinalCD TheFinalCD 4 months ago
where you at with atxi

you still in, cut bait, coming back??

trickle nickle @ .48 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173562791

Message in reply to:
I tap it to keep it moving but to answer your question worst .28 I don’t think we’re done just yet this is the first day of three
👍️0
TheFinalCD TheFinalCD 4 months ago
sure just do the same when you see me on a board but not posting


Message in reply to:
I missed it,was busy with other things,thanks for the heads up,appreciated !!
👍️0
TheFinalCD TheFinalCD 4 months ago
filled more .21's will it hold???
👍️0
TheFinalCD TheFinalCD 4 months ago
I sold 4AM this morn the broker alert woke me up...

exited .28's

was so tired this morning after waking up 4am i missed the 9:15 drop to .20

but just re-started a position .226

with bids lower just incase
👍️0
81vette 81vette 4 months ago
Just bought some.23s on the reversal,30% discount today
👍️0
81vette 81vette 4 months ago
I missed it,was busy with other things,thanks for the heads up,appreciated !!
👍️0

Your Recent History

NASDAQ
ATXI
Avenue Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved